Koers Sartorius Stedim Biotech OTC Markets
Aandelen
SDMHF
FR0013154002
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
176,2 USD | +0,69% |
|
0,00% | -33,19% |
04/07 | Sartorius herstelt zich met 15 procent van jaardieptepunt - Oddo-aanbeveling | DP |
03/07 | Sartorius verder gestabiliseerd | DP |
Omzet 2024 * | 2,9 mld. 3,17 mld. | Omzet 2025 * | 3,25 mld. 3,55 mld. | Marktkapitalisatie | 16,87 mld. 18,44 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 302 mln. 330 mln. | Nettowinst (verlies) 2025 * | 417 mln. 456 mln. | EV/omzet 2024 * | 6,61 x |
Nettoschuld 2024 * | 2,27 mld. 2,48 mld. | Nettoschuld 2025 * | 2,17 mld. 2,37 mld. | EV/omzet 2025 * | 5,86 x |
K/w-verhouding 2024 * |
52,3
x | K/w-verhouding 2025 * |
37,2
x | Werknemers | 10.493 |
Dividendrendement 2024 * |
0,42% | Dividendrendement 2025 * |
0,52% | Vrij verhandelbaar | 31,97% |
Recentste transcriptie over Sartorius Stedim Biotech
1 dag | +0,69% | ||
Lopende maand | +6,79% | ||
1 maand | -7,26% | ||
3 maanden | -34,74% | ||
6 maanden | -27,19% | ||
Lopend jaar | -33,19% |
![Extreem 158](/images/extremecours_fleche.png)
![Extreem 158](/images/extremecours_fleche.png)
![Extreem 158](/images/extremecours_fleche.png)
![Extreem 158](/images/extremecours_fleche.png)
![Extreem 135.55](/images/extremecours_fleche.png)
![Extreem 60.06](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 49 | 26-03-19 |
Chairman | 59 | 29-06-07 | |
Chief Tech/Sci/R&D Officer | 59 | 29-04-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 29-06-07 |
Chairman | 59 | 29-06-07 | |
Susan Dexter
BRD | Director/Board Member | 67 | 07-04-15 |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,90% | 182 mld. | |
-1,36% | 104 mld. | |
-7,64% | 45,58 mld. | |
+9,30% | 46,44 mld. | |
+9,63% | 44,34 mld. | |
+13,63% | 29,44 mld. | |
+20,29% | 26,8 mld. | |
-7,12% | 23,82 mld. | |
+4,03% | 22,61 mld. |